Parallax Volatility Advisers, L.P. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$260,655
-59.7%
109,519
-18.8%
0.00%
-100.0%
Q2 2023$646,176
+117.6%
134,901
+191.5%
0.00%
Q3 2022$297,000
-13.4%
46,286
-53.7%
0.00%
Q2 2022$343,000
+63.3%
100,000
+296.8%
0.00%
Q4 2021$210,000
+18.6%
25,200
-1.6%
0.00%
Q3 2021$177,000
+453.1%
25,600
+723.7%
0.00%
Q4 2017$32,0003,1080.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders